Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Recent News
Dr. Elhalawani is an Attending Physician in the Department of Radiation Oncology and Instructor in Radiation Oncology at Harvard Medical School. He completed medical school, internship and residency at Ain Shams University in Cairo, Egypt, followed by a research fellowship in radiation oncology at the University of Texas MD Anderson Cancer Center, and clinical fellowships in radiation oncology at the Cleveland Clinic and the Dana-Farber Brigham Cancer Center. Dr. Elhalawani’s clinical focus is on cancers affecting pediatric patients. He directs his research efforts toward leveraging machine learning and imaging informatics to personalize care for cancer patients. He has a particular interest in integrating multi-parametric magnetic resonance imaging (mpMRI) and quantitative imaging analytics to advance image-guided cancer treatment and surveillance, and has led efforts to develop clinical applications of radiomics analytics in radiation oncology.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions